The Dopamine Hypothesis of Schizophrenia: An Historical and Philosophical Analysis
- 1 March 2011
- journal article
- research article
- Published by Project MUSE in Philosophy, Psychiatry, & Psychology
- Vol. 18 (1), 41-63
- https://doi.org/10.1353/ppp.2011.0005
Abstract
The dopamine (DA) hypothesis of schizophrenia (DHS) has, since its inception over 30 years ago, been among the most prominent etiologic theories in psychiatry. This essay begins by summarizing the history of its emergence and efforts to empirically test it through the examination of (i) cerebrospinal fluid DA metabolites, (ii) neuroendocrine measures, (iii) clinical response to psychostimulants, (iv) brain levels of DA and its metabolites, (v) brain studies of DA receptors, and (vi) genetic association studies. We then examine how successful the DHS has been and by what criteria its performance should be evaluated. In this process, it is critical to distinguish the etiological DHS from the pharmacological DA hypothesis of neuroleptic action. Although the DHS stimulated much science, most efforts to empirically validate it have failed, in contrast with the well-supported pharmacological DA hypothesis of neuroleptic action. Nonetheless, the DHS has held the status of a scientific paradigm defended by some with great avidity. Like other temporally extended theories, the DHS in its most general form is relatively nonspecific and protean in nature. In its evolution through successive more specific forms, often embodying ad hoc modifications of subsidiary hypotheses, it became very difficult to falsify. Although stimulating much research, it has not produced a progressive research program generating various novel and confirmed predictions about schizophrenia. For most of its history, the DHS has lacked a viable competing alternative theory against which it could be incisively compared. Sociological factors, especially the rise to prominence of the biological psychiatry movement, and the conflation of the DHS and the DA theory of antipsychotic drug action have probably played an important role in its persistence. Psychiatry needs theories with higher levels of specificity and falsifiability. As the science of psychiatry matures, the field needs to become more self-critical about the validity of its theories.Keywords
This publication has 65 references indexed in Scilit:
- Historical Development of the Dopamine Hypothesis of SchizophreniaJournal of the History of the Neurosciences, 2002
- Dopa decarboxylase genotypes may influence age at onset of schizophreniaMolecular Psychiatry, 2001
- Increased baseline occupancy of D 2 receptors by dopamine in schizophreniaProceedings of the National Academy of Sciences of the United States of America, 2000
- Do we still believe in the dopamine hypothesis? New data bring new evidenceInternational Journal of Neuropsychopharmacology, 1999
- Assessment of the Central Dopaminergic Index of Plasma HVA in SchizophreniaSchizophrenia Bulletin, 1995
- The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical FoundationsThe British Journal of Psychiatry, 1989
- Cloning and expression of a rat D2 dopamine receptor cDNANature, 1988
- Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studiesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1977
- The Antagonism of Amphetamine-Induced Symptomatology by a NeurolepticAmerican Journal of Psychiatry, 1974
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963